CHEMICAL MEDICAL REAGENTS USE

Brand	Owner (click to sort)	Address	Description
GLIOSTAT	Oxford BioMedica plc	Windrush Court, Transport Way Oxford OX46LT United Kingdom	CHEMICAL MEDICAL REAGENTS FOR USE IN GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING LIPOSOME REAGENTS SUITABLE FOR GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING NUCLEIC ACID FOR GENE THERAPY; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS, CANCER, HIV AND AIDS RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS; PHARMACEUTICAL PREPARATIONS IN THE FIELD OF GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER;CHEMICAL COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS AND RETROVIRAL VECTOR PREPARATIONS;
IMMSTAT	Oxford BioMedica plc	Windrush Court, Transport Way Oxford OX46LT United Kingdom	CHEMICAL MEDICAL REAGENTS FOR USE IN GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING LIPOSOME REAGENTS SUITABLE FOR GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING NUCLEIC ACID FOR GENE THERAPY; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS, CANCER, HIV AND AIDS RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS; PHARMACEUTICAL PREPARATIONS IN THE FIELD OF GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER;IMMUNOSYSTEMS STAT;INSTRUMENTS AND APPARATUS FOR THE ADMINISTRATION OF GENE THERAPY, NAMELY, SYRINGES, SCALPELS, CATHETERS, TUBES FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS; SURGICAL AND MEDICAL APPARATUS AND INSTRUMENTS FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS;
IMMSTAT	Oxford BioMedica plc	Windrush Court, Transport Way Oxford OX46LT United Kingdom	Chemical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acids, viral vectors or non viral vectors for gene therapy; pharmaceutical preparations containing nucleic acids, viral vectors or non viral vectors for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, neurodegenerative disorders, diseases of the eye which result in vision impairment or loss, diseases of the ear which result in hearing impairment or loss, and bodily conditions associated with impaired immune systems; pharmaceutical preparations in the field of gene therapy; pharmaceutical preparations for the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, neurodegenerative disorders, diseases of the eye which result in vision impairment or loss, diseases of the ear which result in hearing impairment or loss, and bodily conditions associated with impaired immune systems;Instruments and apparatus for the administration of gene therapy products, namely, syringes, injectors, scalpels, catheters, indwelling catheters, pumps, tubes for the administration of gene therapy products; surgical instruments for the administration of gene therapy products;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

This invention describes reagent precursors and methods for chemical and biochemical reactions. These reagent precursors that can be activated in solution upon irradiation to generate reagents required for the subsequent chemical reactions. Specifically, photogenerated reagents (PGR) are useful for controlling parallel combinatorial synthesis and various chemical and biochemical reactions.